SE0000234D0 - Antifungal drug composition and drug delivery system - Google Patents
Antifungal drug composition and drug delivery systemInfo
- Publication number
- SE0000234D0 SE0000234D0 SE0000234A SE0000234A SE0000234D0 SE 0000234 D0 SE0000234 D0 SE 0000234D0 SE 0000234 A SE0000234 A SE 0000234A SE 0000234 A SE0000234 A SE 0000234A SE 0000234 D0 SE0000234 D0 SE 0000234D0
- Authority
- SE
- Sweden
- Prior art keywords
- antifungal
- amphotericin
- delivery system
- drug
- composition
- Prior art date
Links
- 239000003429 antifungal agent Substances 0.000 title abstract 3
- 238000012377 drug delivery Methods 0.000 title abstract 2
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 abstract 4
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 abstract 4
- 229960003942 amphotericin b Drugs 0.000 abstract 4
- MAEIEVLCKWDQJH-UHFFFAOYSA-N bumetanide Chemical compound CCCCNC1=CC(C(O)=O)=CC(S(N)(=O)=O)=C1OC1=CC=CC=C1 MAEIEVLCKWDQJH-UHFFFAOYSA-N 0.000 abstract 2
- 229960004064 bumetanide Drugs 0.000 abstract 2
- 231100000433 cytotoxic Toxicity 0.000 abstract 2
- 230000001472 cytotoxic effect Effects 0.000 abstract 2
- 239000003937 drug carrier Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000000843 anti-fungal effect Effects 0.000 abstract 1
- 229940121375 antifungal agent Drugs 0.000 abstract 1
- 210000003527 eukaryotic cell Anatomy 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0000234A SE0000234D0 (sv) | 2000-01-26 | 2000-01-26 | Antifungal drug composition and drug delivery system |
| PCT/SE2000/002458 WO2001054703A1 (en) | 2000-01-26 | 2000-12-07 | Antifungal drug composition and drug delivery system |
| AU22427/01A AU2242701A (en) | 2000-01-26 | 2000-12-07 | Antifungal drug composition and drug delivery system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0000234A SE0000234D0 (sv) | 2000-01-26 | 2000-01-26 | Antifungal drug composition and drug delivery system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE0000234D0 true SE0000234D0 (sv) | 2000-01-26 |
Family
ID=20278224
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE0000234A SE0000234D0 (sv) | 2000-01-26 | 2000-01-26 | Antifungal drug composition and drug delivery system |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2242701A (sv) |
| SE (1) | SE0000234D0 (sv) |
| WO (1) | WO2001054703A1 (sv) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU9084991A (en) * | 1990-11-01 | 1992-05-26 | Board Of Regents, The University Of Texas System | Antifungal activity of and prevention of drug induced nephrotoxicity by methylxanthine analogues |
-
2000
- 2000-01-26 SE SE0000234A patent/SE0000234D0/sv unknown
- 2000-12-07 WO PCT/SE2000/002458 patent/WO2001054703A1/en not_active Ceased
- 2000-12-07 AU AU22427/01A patent/AU2242701A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2242701A (en) | 2001-08-07 |
| WO2001054703A1 (en) | 2001-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69620241D1 (de) | Gonadotropin releasing hormon- antagonisten | |
| DE60223254D1 (de) | Verzögert freisetzende formulierungen von oxymorphon | |
| NZ325060A (en) | Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone | |
| AU2002225772A1 (en) | Therapeutic agents and methods of use thereof for treating an amyloidogenic disease | |
| MXPA03010085A (es) | Composiciones y su uso en la hiperplasia. | |
| TR200402579T4 (tr) | Kristalin monohidrat, bunun imalat yöntemi ve bir ilaç maddesinin imalatında kullanımı | |
| AR027391A1 (es) | Composiciones farmaceuticas de toxina botulinica | |
| MXPA03004883A (es) | Metodo para la estabilizacion de biomoleculas (por ejemplo, insulina) en formulaciones liquidas. | |
| SE9503143D0 (sv) | New preparation | |
| MX9804850A (es) | Antagonistas de hormona liberadora de gonadotropina. | |
| PT881901E (pt) | Novas associacoes de principios activos contendo clopidogrel e um agente anti-trombotico | |
| MX9710206A (es) | Composicion farmaceutica de amiodarone para administracion parenteral. | |
| DK0680326T3 (da) | Farmaceutisk formulering af nikotinafhængighed. | |
| SE0102843D0 (sv) | Stabilized oral pharmaceutical composition containing lodide and lodate and method | |
| DE69911023D1 (de) | Antagonisten des gonadotropin freisetzenden hormons | |
| NO994165L (no) | Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet | |
| DK0663835T3 (da) | Anvendelse af parathormon, dets biologisk aktive fragmenter og relaterede peptider til behandling af graviditet | |
| DK1187611T3 (da) | Oftalmiske histaminholdige sammensætninger og anvendelse deraf | |
| IL132853A (en) | Composition for modulating the human sexual response | |
| MXPA01008993A (es) | Tratamiento de combinacion para depresion y ansiedad. | |
| GB9905663D0 (en) | Iodine preparation composition | |
| UY27373A1 (es) | Formulaciones de interferón beta-humano | |
| AU2173101A (en) | Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride as anti-inflammatory agents | |
| SE0000234D0 (sv) | Antifungal drug composition and drug delivery system | |
| TR200000005T2 (tr) | Sıtmaya karşı ß-alkoksiakrilatlar. |